These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
493 related items for PubMed ID: 25663486
1. Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD). Simon RA, Dazy KM, Waldram JD. Curr Allergy Asthma Rep; 2015 Mar; 15(3):508. PubMed ID: 25663486 [Abstract] [Full Text] [Related]
2. Aspirin-exacerbated respiratory disease and current treatment modalities. Sakalar EG, Muluk NB, Kar M, Cingi C. Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737 [Abstract] [Full Text] [Related]
3. Current complications and treatment of aspirin-exacerbated respiratory disease. Cook KA, Stevenson DD. Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219 [Abstract] [Full Text] [Related]
4. Aspirin desensitization: useful treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in aspirin-exacerbated respiratory disease (AERD)? Klimek L, Dollner R, Pfaar O, Mullol J. Curr Allergy Asthma Rep; 2014 Jun; 14(6):441. PubMed ID: 24682773 [Abstract] [Full Text] [Related]
5. The clinical effectiveness of aspirin desensitization in chronic rhinosinusitis. Williams AN, Woessner KM. Curr Allergy Asthma Rep; 2008 May; 8(3):245-52. PubMed ID: 18589844 [Abstract] [Full Text] [Related]
13. [Does aspirin therapy after desensitization still have a role in treatment of chronic rhinosinusitis with nasal polyposis in the era of biologics?]. Klimek F, Förster-Ruhrmann U, Hagemann J, Cuevas M, Gröger M, Klimek L. HNO; 2024 Jul; 72(7):484-493. PubMed ID: 38409556 [Abstract] [Full Text] [Related]
14. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper. Macy E, Bernstein JA, Castells MC, Gawchik SM, Lee TH, Settipane RA, Simon RA, Wald J, Woessner KM, Aspirin Desensitization Joint Task Force. Ann Allergy Asthma Immunol; 2007 Feb; 98(2):172-4. PubMed ID: 17304886 [Abstract] [Full Text] [Related]
15. Association Between Aspirin-Exacerbated Respiratory Disease and Atherosclerotic Cardiovascular Disease: A Retrospective Review of US Claims Data. Adame MJ, Raji M, Shan Y, Zhang Y, Kuo YF, Tripple JW. J Allergy Clin Immunol Pract; 2023 Nov; 11(11):3445-3453.e6. PubMed ID: 37468040 [Abstract] [Full Text] [Related]
18. Omalizumab in patient with aspirin exacerbated respiratory disease and chronic idiopathic urticaria. Porcaro F, Di Marco A, Cutrera R. Pediatr Pulmonol; 2017 May; 52(5):E26-E28. PubMed ID: 27685608 [Abstract] [Full Text] [Related]
19. Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease. Haque R, White AA, Jackson DJ, Hopkins C. J Allergy Clin Immunol; 2021 Aug; 148(2):283-291. PubMed ID: 34364538 [Abstract] [Full Text] [Related]
20. Aspirin-exacerbated respiratory disease: update on pathogenesis and desensitization. White AA, Stevenson DD. Semin Respir Crit Care Med; 2012 Dec; 33(6):588-94. PubMed ID: 23047310 [Abstract] [Full Text] [Related] Page: [Next] [New Search]